OQROGet OQRO Pro
Insider trade

Aprea Therapeutics (APRE)CEO bought ~$725

Oren Gilad, CEO at Aprea Therapeutics, bought ~$725 of Aprea Therapeutics shares.

~$725
Approx. value · 250 sh @ $2.90
333K
Holds after · shares reported
Traded
Oct 15, 2024
Filed
Oct 16, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 10, 2024Insider · 2 peopleInsiders: 2 purchases (~$2K)
  2. Oct 11, 2024Insider · 2 peopleInsiders: 2 purchases (~$27K)
  3. Oct 14, 2024Insider · 2 peopleInsiders: 2 purchases (~$3K)
  4. Oct 15, 2024 · this disclosureInsiderCEO purchased ~$725 of APRE shares in the open market

What came next

  1. Oct 16, 2024InsiderDirector purchased ~$132K of APRE shares in the open market
  2. Oct 18, 2024InsiderDirector sold ~$30K of APRE shares in the open market
  3. Oct 23, 2024InsiderCEO purchased ~$2K of APRE shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Aprea Therapeutics

OQRO holds no insider, Congress, fund or contract record for Aprea Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its APRE page.

Other recent filings by Oren Gilad, President/CEO

The full history of Oren Gilad, President/CEO is on the profile page.

How this filing works

Other disclosures at Aprea Therapeutics

Everything OQRO holds on this company is on its APRE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data